Association of monocyte chemoattractant protein-1 (MCP-1) 2518A/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes

Yonsei Medical Journal

Volumn 54, Issue 3, 2013, Pages 621-625

  Jeon, Hyun Jeong ^a   Choi, Hyung Jin ^a   Park, Byong Hee ^a   Lee, Yong Hee ^a   Oh, Taekeun ^a  

^a Chungbuk National University College of Medicine   (South Korea)

Author keywords

MCP 1 polymorphism; Proliferative diabetic retinopathy; Type 2 DM

Indexed keywords

C PEPTIDE; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PREVALENCE; RATING SCALE; SINGLE NUCLEOTIDE POLYMORPHISM; UREA NITROGEN BLOOD LEVEL;

MCP-1 POLYMORPHISM; PROLIFERATIVE DIABETIC RETINOPATHY; TYPE 2 DM;

AGED; CASE-CONTROL STUDIES; CHEMOKINE CCL2; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA;

EID: 84875907612     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2013.54.3.621     Document Type: Article

References (23)

1. Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med 2012;366:1227-1239.
2. Adamiec-Mroczek J, Oficjalska-Młyńczak J, Misiuk-Hojło M. Proliferative diabetic retinopathy-the infuence of diabetes control on the activation of the intraocular molecule system. Diabetes Res Clin Pract 2009;84:46-50.
3. Leal EC, Santiago AR, Ambrósio AF. Old and new drug targets in diabetic retinopathy: from biochemical changes to infammation and neurodegeneration. Curr Drug Targets CNS Neurol Disord 2005;4:421-434.
4. Fong DS, Aiello LP, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care 2004;27:2540-2553.
5. Simó R, Carrasco E, García-Ramírez M, Hernández C. Angiogen-ic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev 2006;2:71-98.
6. Crawford TN, Alfaro DV 3rd, Kerrison JB, Jablon EP. Diabetic retinopathy and angiogenesis. Curr Diabetes Rev 2009;5:8-13.
7. Hernández C, Burgos R, Cantón A, García-Arumí J, Segura RM, Simó R. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study. Diabetes Care 2001;24: 516-521.
8. Beránek M, Kanková K, Benes P, Izakovicová-Hollá L, Znojil V, Hájek D, et al. Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identifed risk factor for proliferative diabetic retinopathy. Am J Med Genet 2002;109:278-283.
9. Niu J, Kolattukudy PE. Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Clin Sci (Lond) 2009;117:95-109.
10. Kolattukudy PE, Niu J. Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/ CCR2 pathway. Circ Res 2012;110:174-189.
11. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte che-moattractant protein-1 (MCP-1): an overview. J Interferon Cyto-kine Res 2009;29:313-326.
12. Capeans C, De Rojas MV, Lojo S, Salorio MS. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy. Retina 1998;18:546-550.
13. Mitamura Y, Takeuchi S, Matsuda A, Tagawa Y, Mizue Y, Nishi-hira J. Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy. Ophthalmologica 2001; 215:415-418.
14. Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Bio-chem Biophys Res Commun 1999;259:344-8.
15. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and Classification of diabetes mellitus. Diabetes Care 2003;26 Suppl 1:S5-20.
16. Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Imamura K, Ishibashi F, et al. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for diabetic retinopathy in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract 2010;89:e9-e12.
17. Malecki MT, Cyganek K, Mirkiewicz-Sieradzka B, Wolkow PP, Wanic K, Skupien J, et al. Alanine variant of the Pro12Ala polymorphism of the PPARgamma gene might be associated with decreased risk of diabetic retinopathy in type 2 diabetes. Diabetes Res Clin Pract 2008;80:139-145.
18. Petrovic MG, Kunej T, Peterlin B, Dovc P, Petrovic D. Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 gene might be a risk factor for diabetic reti-nopathy in Slovene population (Caucasians) with type 2 diabetes and the Pro12Ala polymorphism of the PPARgamma gene is not. Diabetes Metab Res Rev 2005;21:470-474.
19. Stefanski A, Majkowska L, Ciechanowicz A, Frankow M, Saf-ranow K, Parczewski M, et al. Lack of association between the Pro-12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes. Arch Med Res 2006;37:736-743.
20. Yoshioka K, Yoshida T, Kogure A, Takakura Y, Umekawa T. Monocyte chemoattractant protein-1 -2518 polymorphism is not associated with diabetic retinopathy in Japanese type 2 diabetes. Diabetes Metab Syndr: Clin Res Rev 2009;3:166-168.
21. Moon JY, Jeong L, Lee S, Jeong K, Lee T, Ihm CG, et al. Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus. J Korean Med Sci 2007;22:810-814.
22. Kim HL, Lee DS, Yang SH, Lim CS, Chung JH, Kim S, et al. The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE. Am J Kidney Dis 2002;40:1146-1152.
23. Buraczynska M, Bednarek-Skublewska A, Buraczynska K, Ksi-azek A. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients. Cytokine 2008;44:361-365.